+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Cell and Gene Therapy Market Forecast to 2031 - Regional Analysis - by Type, Services, Scale, Service Providers, and End User

  • PDF Icon

    Report

  • 161 Pages
  • April 2025
  • Region: Asia Pacific
  • The Insight Partners
  • ID: 6109130
Description Jump to:
The Asia Pacific cell and gene therapy market was valued at US$ 1.02 billion in 2023 and is projected to reach US$ 8.01 billion by 2031; it is estimated to record a CAGR of 29.3% from 2023 to 2031.

Strategic Initiatives by Companies Drive Asia Pacific Cell and Gene Therapy Market

Many companies involved in manufacturing cell and gene therapy products focus on collaborations, expansions, agreements, partnerships, new product launches, and other strategic developments. These strategic initiatives help them improve sales, expand geographic reach, and enhance capacities to cater to a large customer base. A few of the significant developments in the cell and gene therapy market are; In September 2023, Agilent Technologies Inc. signed a Memorandum of Understanding (MOU) with the Advanced Cell Therapy and Research Institute, Singapore (ACTRIS). This agreement aims to improve cell and gene therapy advancements over the next three years. In March 2023, Cellevolve Bio partnered with Seattle Children's Therapeutics to develop and commercialize new multiplex CARs for pediatric cancers. With this collaboration, the companies will focus on the BrainChild research program-a suite of five multiplex CARs-to treat pediatric central nervous system (CNS) malignancies. They aim to leverage the Seattle Children's Cure Factory facility to conduct early clinical GMP research on new CARs. In March 2023, Twist Bioscience Corporation and Kriya Therapeutics, Inc. entered an antibody discovery agreement for antibodies delivered using adeno-associated viral (AAV) gene therapy in therapeutic oncology applications. Also, the companies aim to combine Twist's antibody libraries with Kriya's proprietary vector engineering platform to discover novel antibodies against specific targets of interest to be delivered with Kriya's gene therapy technology. In January 2023, FUJIFILM Corporation agreed to acquire a cell therapy manufacturing facility from Atara Biotherapeutics, Inc. The facility will witness expansion with the flexibility to produce clinical as well as commercial cell therapies, such as allogeneic T-cell and CAR T immunotherapies. The initiation of new businesses to remain competitive in the market through collaborations and partnerships can help accelerate the development of new platforms for cell and gene therapy manufacturing services. Thus, these strategic initiatives by key players are anticipated to create substantial growth opportunities in the Asia Pacific cell and gene therapy market during the forecast period.

Asia Pacific Cell and Gene Therapy Market Overview

China is making progress in gene and cell therapy. The country has a large patient population making it an attractive market for companies developing these treatments. Several companies are working on innovative therapies for diseases such as cancer and genetic disorders in China, and the country has invested heavily in gene therapy research and development. China was the first country to approve gene therapy in 2003; since then, cell and gene therapy developments have advanced rapidly worldwide, and their therapeutic potential has soared. The government of the People's Republic of China has conducted several regulatory reforms to promote the normative development of cell and gene therapies. According to a study published in Nature in 2021, China is home to more than 50% of all cell therapy trials worldwide. China has nearly 400 ongoing CAR-T trials centered on hematology, oncology, and solid tumors. Cell therapy in China is entering a new era with the approval of Fosun Kite's Yescarta and JW Therapeutics' Relma-cel in 2021 from the National Medical Products Administration (NMPA). In October 2023, CARsgen and IASO Biotherapeutics/Innovent were approved by the NMPA for new drug approvals targeting B-cell maturation antigens in CAR-T. These therapies are expected to be approved and commercialized soon.

Asia Pacific Cell and Gene Therapy Market Segmentation

The Asia Pacific cell and gene therapy market is categorized into type, services, scale, end user, and country.

Based on type, the Asia Pacific cell and gene therapy market is bifurcated into cell therapy and gene therapy. The cell therapy segment held a larger market share in 2023. Furthermore, the cell therapy segment is sub segmented into allogeneic, autologous, viral vectors. Additionally, the gene therapy segment is divided into non-viral vectors and viral vectors.

In terms of services, the Asia Pacific cell and gene therapy market is categorized process development, cGMP manufacturing, regulatory services, and bioassay services. The process development segment held the largest market share in 2023.

By scale, the Asia Pacific cell and gene therapy market is bifurcated into pre-commercial/R&D manufacturing and commercial scale manufacturing. The pre-commercial/R&D manufacturing segment held a larger market share in 2023.

Based on end user, the Asia Pacific cell and gene therapy market is segmented into contract research organizations, pharmaceutical and biopharmaceutical companies, and academic and research institutes. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2023.

By country, the Asia Pacific cell and gene therapy market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific cell and gene therapy market share in 2023.

Catalent Inc, Charles River Laboratories International Inc, F. Hoffmann-La Roche Ltd, FUJIFILM Holdings Corp, Lonza Group AG, Lotte Corp, Merck KGaA, Takara Bio Inc, Thermo Fisher Scientific Inc., and WuXi AppTec Co Ltd are some of the leading companies operating in the Asia Pacific cell and gene therapy market.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific cell and gene therapy market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific cell and gene therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific cell and gene therapy market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Asia Pacific Cell and Gene Therapy Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Asia Pacific Cell and Gene Therapy Market - Key Market Dynamics
5.1 Cell and Gene Therapy Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Increase in Number of Approval of Cell and Gene Therapies
5.2.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing
5.3 Market Restraints
5.3.1 High Cost of Cell and Gene Therapy Manufacturing
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Companies
5.5 Future Trends
5.5.1 Automation of Cell and Gene Therapy Manufacturing Services
5.6 Impact of Drivers and Restraints:
6. Cell and Gene Therapy Market -Asia Pacific Market Analysis
6.1 Asia Pacific Cell and Gene Therapy Market Overview
6.2 Asia Pacific Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
6.3 Cell and Gene Therapy Market Forecast Analysis
7. Asia Pacific Cell and Gene Therapy Market Analysis - by Type
7.1 Cell Therapy
7.1.1 Overview
7.1.2 Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Gene Therapy
7.2.1 Overview
7.2.2 Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8. Asia Pacific Cell and Gene Therapy Market Analysis - by Services
8.1 Process Development
8.1.1 Overview
8.1.2 Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.2 cGMP Manufacturing
8.2.1 Overview
8.2.2 cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Regulatory Services
8.3.1 Overview
8.3.2 Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Bioassay Services
8.4.1 Overview
8.4.2 Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
9. Asia Pacific Cell and Gene Therapy Market Analysis - by Scale
9.1 Pre-Commercial/R&D Manufacturing
9.1.1 Overview
9.1.2 Pre-Commercial/R&D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Commercial Scale Manufacturing
9.2.1 Overview
9.2.2 Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
10. Asia Pacific Cell and Gene Therapy Market Analysis - by Service Providers
10.1 CDMOs
10.1.1 Overview
10.1.2 CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
10.2 CMOs
10.2.1 Overview
10.2.2 CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11. Asia Pacific Cell and Gene Therapy Market Analysis - by End User
11.1 Contract Research Organizations
11.1.1 Overview
11.1.2 Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11.2 Pharmaceutical and Biopharmaceutical Companies
11.2.1 Overview
11.2.2 Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Academic and Research Institutes
11.3.1 Overview
11.3.2 Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12. Asia Pacific Cell and Gene Therapy Market - Country Analysis
12.1 Asia Pacific Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1 Asia Pacific Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
12.1.1.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
12.1.1.2 China: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.2.1 China: Cell and Gene Therapy Market Breakdown, by Type
12.1.1.2.1.1 China: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.1.1.2.1.2 China: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.1.1.2.2 China: Cell and Gene Therapy Market Breakdown, by Services
12.1.1.2.3 China: Cell and Gene Therapy Market Breakdown, by Scale
12.1.1.2.4 China: Cell and Gene Therapy Market Breakdown, by Service Providers
12.1.1.2.5 China: Cell and Gene Therapy Market Breakdown, by End User
12.1.1.3 Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.3.1 Japan: Cell and Gene Therapy Market Breakdown, by Type
12.1.1.3.1.1 Japan: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.1.1.3.1.2 Japan: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.1.1.3.2 Japan: Cell and Gene Therapy Market Breakdown, by Services
12.1.1.3.3 Japan: Cell and Gene Therapy Market Breakdown, by Scale
12.1.1.3.4 Japan: Cell and Gene Therapy Market Breakdown, by Service Providers
12.1.1.3.5 Japan: Cell and Gene Therapy Market Breakdown, by End User
12.1.1.4 India: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.4.1 India: Cell and Gene Therapy Market Breakdown, by Type
12.1.1.4.1.1 India: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.1.1.4.1.2 India: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.1.1.4.2 India: Cell and Gene Therapy Market Breakdown, by Services
12.1.1.4.3 India: Cell and Gene Therapy Market Breakdown, by Scale
12.1.1.4.4 India: Cell and Gene Therapy Market Breakdown, by Service Providers
12.1.1.4.5 India: Cell and Gene Therapy Market Breakdown, by End User
12.1.1.5 Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.5.1 Australia: Cell and Gene Therapy Market Breakdown, by Type
12.1.1.5.1.1 Australia: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.1.1.5.1.2 Australia: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.1.1.5.2 Australia: Cell and Gene Therapy Market Breakdown, by Services
12.1.1.5.3 Australia: Cell and Gene Therapy Market Breakdown, by Scale
12.1.1.5.4 Australia: Cell and Gene Therapy Market Breakdown, by Service Providers
12.1.1.5.5 Australia: Cell and Gene Therapy Market Breakdown, by End User
12.1.1.6 South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.6.1 South Korea: Cell and Gene Therapy Market Breakdown, by Type
12.1.1.6.1.1 South Korea: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.1.1.6.1.2 South Korea: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.1.1.6.2 South Korea: Cell and Gene Therapy Market Breakdown, by Services
12.1.1.6.3 South Korea: Cell and Gene Therapy Market Breakdown, by Scale
12.1.1.6.4 South Korea: Cell and Gene Therapy Market Breakdown, by Service Providers
12.1.1.6.5 South Korea: Cell and Gene Therapy Market Breakdown, by End User
12.1.1.7 Rest of Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.7.1 Rest of Asia Pacific: Cell and Gene Therapy Market Breakdown, by Type
12.1.1.7.1.1 Rest of Asia Pacific: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.1.1.7.1.2 Rest of Asia Pacific: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.1.1.7.2 Rest of Asia Pacific: Cell and Gene Therapy Market Breakdown, by Services
12.1.1.7.3 Rest of Asia Pacific: Cell and Gene Therapy Market Breakdown, by Scale
12.1.1.7.4 Rest of Asia Pacific: Cell and Gene Therapy Market Breakdown, by Service Providers
12.1.1.7.5 Rest of Asia Pacific: Cell and Gene Therapy Market Breakdown, by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in Cell and Gene Therapy Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Thermo Fisher Scientific Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Merck KGaA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Charles River Laboratories International Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Lonza Group AG
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 WuXi AppTec Co Ltd
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Takara Bio Inc
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 FUJIFILM Holdings Corp
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 F. Hoffmann-La Roche Ltd
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Catalent Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Lotte Corp
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms
List of Tables
Table 1. Cell and Gene Therapy Market Segmentation
Table 2. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 4. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Cell Therapy
Table 5. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Gene Therapy
Table 6. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Services
Table 7. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Scale
Table 8. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Service Providers
Table 9. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 10. Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 11. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 12. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 13. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 14. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 15. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 16. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 17. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 18. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 19. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 20. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 21. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 22. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 23. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 24. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 25. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 26. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 27. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 28. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 29. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 30. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 31. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 32. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 33. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 34. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 35. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 36. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 37. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 38. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 39. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 40. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 41. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 42. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 43. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 44. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 45. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 46. Rest of Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 47. Rest of Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 48. Rest of Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 49. Rest of Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 50. Rest of Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 51. Rest of Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 52. Rest of Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 53. Recent Organic Growth Strategies in Cell and Gene Therapy Market
Table 54. Recent Inorganic Growth Strategies in the Cell and Gene Therapy Market
Table 55. Glossary of Terms
List of Figures
Figure 1. Cell and Gene Therapy Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
Figure 5. Cell and Gene Therapy Market Share (%) - by Type (2023 and 2031)
Figure 6. Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Cell and Gene Therapy Market Share (%) - by Services (2023 and 2031)
Figure 9. Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Cell and Gene Therapy Market Share (%) - by Scale (2023 and 2031)
Figure 14. Pre-Commercial/R&D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Cell and Gene Therapy Market Share (%) - by Service Providers (2023 and 2031)
Figure 17. CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Cell and Gene Therapy Market Share (%) - by End User (2023 and 2031)
Figure 20. Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Asia Pacific Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 24. Asia Pacific Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 25. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 26. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 27. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 28. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 29. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 30. Rest of Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 31. Growth Strategies in Cell and Gene Therapy Market

Companies Mentioned

Some of the leading companies in the Asia Pacific Cell and Gene Therapy Market include:
  • Catalent Inc
  • Charles River Laboratories International Inc
  • F. Hoffmann-La Roche Ltd
  • FUJIFILM Holdings Corp
  • Lonza Group AG
  • Lotte Corp
  • Merck KGaA
  • Takara Bio Inc
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co Ltd

Table Information

Report AttributeDetails
No. of Pages161
PublishedApril 2025
Forecast Period2023 - 2031
Estimated Market Value in 2023 1024.37 Million in 2023
Forecasted Market Value by 2031 8012.75 Million by 2031
Compound Annual Growth Rate29.3%
Regions CoveredAsia Pacific
No. of Companies Mentioned11

Related Topics

Related Reports

Cell and Gene Therapy Contract Development and Manufacturing Organization Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type, Product Type, End User, and Geography - Product Image

Cell and Gene Therapy Contract Development and Manufacturing Organization Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type, Product Type, End User, and Geography

  • Report
  • 249 Pages
  • Global
From
Cell and Gene Therapy Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend and Growth Opportunity Analysis Report Coverage: By Type, Services, Scale, Service Providers, End User and Geography - Product Image

Cell and Gene Therapy Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend and Growth Opportunity Analysis Report Coverage: By Type, Services, Scale, Service Providers, End User and Geography

  • Report
  • 232 Pages
  • Global
From
Cell and Gene Therapy Manufacturing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031 - Product Image

Cell and Gene Therapy Manufacturing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031

  • Report
  • 115 Pages
  • Global
From
Europe Cell and Gene Therapy Market Forecast to 2031 - Regional Analysis - by Type, Services, Scale, Service Providers, and End User - Product Image

Europe Cell and Gene Therapy Market Forecast to 2031 - Regional Analysis - by Type, Services, Scale, Service Providers, and End User

  • Report
  • 163 Pages
  • Europe
From
Middle East & Africa Cell and Gene Therapy Market Forecast to 2031 - Regional Analysis - by Type, Services, Scale, Service Providers, and End User - Product Image

Middle East & Africa Cell and Gene Therapy Market Forecast to 2031 - Regional Analysis - by Type, Services, Scale, Service Providers, and End User

  • Report
  • 150 Pages
  • Africa, Middle East
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.